Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1987-04-14
1989-08-29
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Lymphokine
514 2, 514 12, 514 8, A61K 3702
Patent
active
048615870
ABSTRACT:
The use of TNF for the prophylaxis and therapy of radiaton damage is described.
REFERENCES:
patent: 4275056 (1981-06-01), Takaku et al.
Muir's Textbook of Pathology, 10th Ed. (1976) pp. 23-29, "Cell Damage Due to Ionising Radiation" and p. 259.
Broudy et al., cited in Chem. Abstracts, vol. 105:189177p (1986).
Carswell et al., PNAS U.S.A., vol. 72, No. 9, pp. 3666-3670, Sep. 1975.
Stankovic, cited in Chem. Abstracts, vol. 74:38912q (1971).
Nature, vol. 312, (1984), pp. 724-729.
Broudy et al. (1986), Proc. Natl. Acad. Aci. USA, 83:7467-7471.
Activation of Human Polymorphonuclear Neutrophil Functions by Interferon-.gamma. and Tumor Necrosis Factors, J. of Immuno. (1985)135, No. 3:2069-2073-Shalaby et al.
Maennel Daniela
Urbaschek Bernhard
Urbaschek Renate
BASF - Aktiengesellschaft
Brown Johnnie R.
Stone Jacqueline M.
LandOfFree
Use of TNF for the prevention or treatment of radiation damage does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of TNF for the prevention or treatment of radiation damage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of TNF for the prevention or treatment of radiation damage will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2236975